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Abstract
Degradation of elastin leads to the production of elastin-derived peptides (EDP), which ex-
hibit several biological effects, such as cell proliferation or protease secretion. Binding of
EDP on the elastin receptor complex (ERC) triggers lactosylceramide (LacCer) production
and ERK1/2 activation following ERC Neu-1 subunit activation. The ability for ERC to trans-
duce signals is lost during aging, but the mechanism involved is still unknown. In this study,
we characterized an in vitromodel of aging by subculturing human dermal fibroblasts. This
model was used to understand the loss of EDP biological activities during aging. Our results
show that ERC uncoupling does not rely on Neu-1 or PPCAmRNA or protein level changes.
Furthermore, we observe that the membrane targeting of these subunits is not affected with
aging. However, we evidence that Neu-1 activity and LacCer production are altered. Basal
Neu-1 catalytic activity is strongly increased in aged cells. Consequently, EDP fail to pro-
mote Neu-1 catalytic activity and LacCer production in these cells. In conclusion, we pro-
pose, for the first time, an explanation for ERC uncoupling based on the age-related
alterations of Neu-1 activity and LacCer production that may explain the loss of EDP-medi-
ated effects occurring during aging.
Introduction
Elastin is an extracellular matrix protein important for the structural integrity and function of
tissues undergoing reversible extensibility or deformability, such as lungs, arteries and skin
[1,2]. This protein, deposited during the early stages of life [3], is extremely stable and resistant.
With a typical half-life estimated at 70 years, elastin is present for life and undergoes virtually
PLOSONE | DOI:10.1371/journal.pone.0129994 June 18, 2015 1 / 18
OPEN ACCESS
Citation: Scandolera A, Rabenoelina F, Chaintreuil
C, Rusciani A, Maurice P, Blaise S, et al. (2015)
Uncoupling of Elastin Complex Receptor during In
Vitro Aging Is Related to Modifications in Its Intrinsic
Sialidase Activity and the Subsequent
Lactosylceramide Production. PLoS ONE 10(6):
e0129994. doi:10.1371/journal.pone.0129994
Academic Editor: Neeraj Vij, Central Michigan
University School of Medicine, UNITED STATES
Received: December 19, 2014
Accepted: May 15, 2015
Published: June 18, 2015
Copyright: © 2015 Scandolera et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by grants from
the CNRS (Centre National de la Recherche
Scientifique) and the Ministère de l’Enseignement
Supérieur et de la Recherche. Amandine Scandolera
is a fellow of the Ministère de l’Enseignement
Supérieur et de la Recherche. The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
no turnover [4]. Nevertheless, during aging, mechanical stress and elastase activities contribute
to the fragmentation of this macropolymer into elastin-derived peptides (EDP) [5].
While elastin is devoid of biological activity, EDP have been shown to regulate several bio-
logical processes such as immune response [6,7], chemoattraction [8], cell proliferation [9],
proteases expression [10,11], calcium modulation [12], NO (Nitric Oxide) production [13,14],
matrix synthesis [10,14–16] and cell migration [15,17]. As a consequence, EDP, which concen-
tration increases in blood circulation with age [6], are thought to be involved in several aging-
related pathologies such as atherosclerosis [18] and cancer [15,16,19–21].
Biologically active EDP possess a GXXPG consensus sequence adopting a type VIII β-turn
structure [22,23] involved in their binding to the elastin receptor complex (ERC) [24]. This re-
ceptor contains three subunits: a peripheral 67-kDa protein named elastin-binding protein
(EBP, accession number P16278-2), and two membrane-associated proteins, the protective
protein/cathepsin A (PPCA, 55-kDa, accession number P10619) and neuraminidase-1 (Neu-1,
61-kDa, accession number Q99519) [25]. EBP is an enzymatically inactive spliced variant of ly-
sosomal β-galactosidase [26,27]. It possesses two functional binding sites: the elastin site on
which EDP bind triggering signaling pathways, and a galactolectin site whom occupancy by
galactosugars induces EDP release, dissociation of the complex and signal loss [25].
EDP binding to EBP leads to Neu-1 activation and lactosylceramide (LacCer) generation
through the desialylation of its substrate, the GM3 ganglioside [28]. This lipid conversion fur-
ther induces the activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway
[29] via a mechanism requiring both p110γ /Raf-1 and PKA/B-Raf signaling [30,31].
The biological effects induced by EDP are modified with aging. Varga et al and Faury et al
suggested that the function and availability of the ERC could change with aging in leukocytes
[32,33] and in arteries [13]. These effects were not explained by modifications of EBP expres-
sion and/or affinity [34] but, possibly, by altered receptor functioning and/or alteration of ac-
tors of the downstream signaling pathways [35]. Until now, the cause of this uncoupling is still
a matter of speculation.
As ERC is involved in EDP-induced signal transduction [7,29,36,37] but also in elastogen-
esis through tropoelastin binding and secretion [25,38,39], it is of high interest to understand
the mechanism leading to its age-related uncoupling.
In this study, we demonstrate that ERC uncoupling observed in an in vitromodel of fibro-
blast aging is not linked to modifications of its mRNA, protein levels, or membrane targeting.
However, we evidence that EDP-triggered lactosylceramide production and Neu-1 sialidase ac-
tivity is reduced in aged cells. We also showed that these processes are associated with a drastic
elevation of the basal catalytic activity of Neu-1 to a level being no more increasable by EDP
stimulation. We therefore propose that ERC uncoupling could originate from its unability to
regulate Neu-1 activity and lactosylceramide production.
Materials and Methods
Reagents
Elastin peptides were prepared as described by Rusciani et al [28]. Briefly, insoluble elastin was
prepared from bovine ligamentum nuchae by hot alkali treatment. Comparing its amino acid
composition to that predicted from the elastin gene product assessed its purity. Soluble elastin
peptides were further obtained from insoluble elastin by organo-alkaline hydrolysis. This was
achieved using 1 M KOH in 80% aqueous ethanol. The obtained mixture of elastin peptides is
termed κ-elastin (kE) and exhibits the same biological properties as physiological elastin hy-
drolysates obtained using elastase [10]. Indeed, this mixture of EDP has been shown to contain
several peptides harboring the bioactive GxxPG motifs [29].
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The synthetic peptides, VGVAPG and its VVGPGA scramble, were obtained from Genecust
(purity>98%) (Dudelange, Luxembourg). Dulbecco’s Modified Eagle’s Medium (DMEM), an-
tibiotics and fungizone were purchased from Life Technologies (Saint Aubin, France). Fetal
calf serum (FCS) was obtained from PAA Laboratories (Velizy-Villacoublay, France). BCA
assay Protein Quantification Kit and Uptiblue reagent were from Interchim (Montluçon,
France). All generic chemical products were obtained from Sigma-Aldrich (Saint-Quentin Fal-
lavier, France). 2,3-dehydro-2-deoxy-N-acetylneuraminic acid (DANA) was used as a Neu-1
inhibitor [29,40] and was purchased fromMerck (Molsheim, Fance). The Image-iT LIVE
Green Reactive Oxygen Species Detection Kit (Molecular Probes) was obtained from Invitro-
gen (Cergy-Pontoise, France).
Antibodies
Alexafluor-568 goat anti-rabbit antibodies were from Molecular Probes (Saint Aubin, France).
Anti-phospho-ERK1/2, anti-actin and anti-Neu-1 (H-300) polyclonal antibodies were ob-
tained from Santa Cruz (distributed by Tebu, Le Perray en Yvelines, France). Anti-ERK1/2 an-
tibody was purchased from Cell Signaling Technology Inc. (Beverly, MA, distributed by
Ozyme, Saint Quentin en Yvelines, France). FITC-conjugated anti-CD17 antibody (anti-Lac-
Cer) and FITC-labeled isotype control were from Ancell, distributed by Covalab (Villeurbanne,
France). Fluorochrome-coupled anti-rabbit or anti-mouse secondary antibodies were obtained
from Invitrogen. HRP-coupled anti-mouse antibody was purchased from Life Technology.
HRP-coupled anti-goat antibody was obtained from Sigma-Aldrich.
Ethics statement
Human skin fibroblasts were established from explants of human adult skin biopsies obtained
from informed healthy volunteers (aged 33–44 years) who have given their written consent.
The experiments were conducted according with the recommendations of "Le Centre National
de la Recherche Scientifique" (CNRS, France) that has specifically approved this study. Collec-
tion and utilization of human skin biopsies were approved by the Institutional Review Board of
the Reims University Hospital (CHU de Reims).
Fibroblasts isolation, cell culture and treatments
Human dermal fibroblasts were isolated from skin biopsies of healthy subjects and were ob-
tained using cell culture medium selection [41]. Briefly, the hypodermis was mechanically
eliminated and explants were cut into 1 mm2 pieces. Skin fragments were then cultivated at
37°C/5% CO2 in 75 cm
2 cell culture dishes containing 10 mL of DMEMmedium supplemented
with 20% FCS, 1% antibiotics (penicillin, streptomycin) and 1% fungizone. The medium was
changed every two days. After 4 weeks of culture, fibroblasts have covered all the surface of the
culture dishes and were trypsined. Cells were cultured at 37°C/5% CO2 in monolayers in
DMEM containing 1g/L of glucose, Glutamax I and pyruvate supplemented with 10% FCS.
Subcultures 3 to 10 were used in this study.
Before all experiments, cells were starved for 18 hours by FCS privation in order to synchro-
nize them. Fibroblasts were then stimulated or not with 50 μg/mL EDP or 200 μg/mL
VGVAPG or VVGPGA peptides in basal medium. To inhibit Neu-1 activity, fibroblasts were
pre-incubated for 1 h with 400 μMDANA then stimulated as described above. Stimulation was
stopped by adding cold phosphate buffered saline (PBS) containing 50 μMNa3VO4.
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Acid β-galactosidase assay
The detection of β-galactosidase activity at pH6 is a specific biomarker of cellular senescence
[42,43]. Cells (3.105) were seeded in a 6-well plate in medium containing 10% FCS and 1% anti-
biotics. After 48 hours of culture followed by an 18h-serum starvation period β-galactosidase
staining was performed using a β-galactosidase staining kit (Cell Signaling, Danvers USA).
Cells were washed twice in PBS then fixed for 10 minutes at room temperature with 2% formal-
dehyde and 0.2% glutaraldehyde in PBS. After two washes in PBS, cells were incubated over-
night at 37°C with β-galactosidase staining solution containing 1X staining solution (40 mM
citric acid/sodium phosphate pH6, 150 mMNaCl and 2 mMMgCl2), 1X staining solution sup-
plement A (5 nM potassium ferrocyanide), 1X staining solution supplement B (5 nM potassi-
um ferricyanide) and 1 mg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside).
Three pictures were taken per well and the stained cells were counted.
Proliferation assays
Fibroblasts (1.105) were seeded in 24-well plates in complete DMEMmedium. After 48 hours
of culture, cells were starved during 18 hours by serum privation then stimulated for 48h with
50 μg/mL of EDP or 200 μg/mL VGVAPG or scramble peptide in basal medium. Cellular pro-
liferation was analyzed by two different approaches: manual counting after Trypan blue stain-
ing and by colorimetry with the Uptiblue reagent. For manual counting, cells were detached by
trypsin incubation, stained using Trypan Blue then counted using a KOVA cell. As described
by the manufacturer, the UptiBlue method uses a colorimetric growth indicator based on the
detection of metabolic activity. It depends on a redox indicator that changes color in response
to chemical reduction of growth medium resulting from cell growth, allowing to determine cell
proliferation [44]. After the stimulation period, fibroblasts were incubated with the Uptiblue
reagent for 4 hours at 37°C. Cell proliferation was then evaluated by absorbance at 560 nm.
Reactive oxygen species (ROS) detection
Fibroblasts (1.105) were seeded in a 24-well plate in complete DMEMmedium. After 48 hours
of culture followed by an 18h serum starvation period, cells were stimulated by 50 μg/mL EDP
or 200 μg/mL VGVAPG or VVGPGA for 30 minutes. ROS production was determined using
the Image-iT LIVE Green Reactive Oxygen Species Detection Kit according to the manufactur-
er’s instructions. ROS were detected after incubation for 30 minutes in darkness with 25 μM
carboxy-2',7'-dichlorodihydrofluorescein diacetate, a chemically reduced analogue of fluoresce-
in used as an indicator of ROS production in cells. Cells were then washed twice in PBS and ox-
idation products were detected by fluorescence (excitation at 495 nm, emission at 529 nm).
MMP-1 ELISA Assay
Fibroblasts (3.105) were seeded in a 6-well plate in DMEMmedium containing 10% FCS and
1% antibiotics. After 48h of culture, cells were serum-starved for 18h then stimulated by 50 μg/
mL EDP or 200 μg/mL VGVAPG or VVGPGA peptide during 24 hours. The supernatants
were collected and MMP-1 secretion was detected by ELISA (Calbiochem, Darmstadt, Ger-
many). Briefly, samples (standards and conditioned mediums) were incubated for 2 hours at
room temperature in a 96-well plate pre-coated with MMP-1 antibodies. After washes with
PBS, HRP-conjugated MMP-1 was added during 1 hour at room temperature. Bound MMP-1
was detected by adding the chromogenic substrate tetra-methylbenzidine for 30 minutes at
room temperature in darkness. The reaction was stopped by addition of 2.5 N sulfuric acid.
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MMP-1 detection was analyzed by reading absorbance at 450 nm using a micro-plate reader
(TECAN) coupled to the Magellan software.
Western blotting
Fibroblasts (3.105) were seeded in a 6-well plate in complete DMEMmedium. After 48h of cul-
ture, cells were serum-starved for 18h then stimulated with 50 μg/mL EDP for 24 hours. Reac-
tion was stopped by adding ice-cold PBS containing 50 μMNa3VO4. Fibroblasts were then
washed twice in ice-cold PBS containing 50 μMNa3VO4, scrapped and sonicated in lysis buffer
(PBS, pH7.4, 0.5% Triton X-100, 80 mM glycerophosphate, 50 mM EGTA, 15 mMMgCl2, 1
mMNa3VO4 and protease inhibitor cocktail (Sigma-Aldrich)). Insoluble material was removed
by centrifugation (20000g, 45 min, 4°C). Protein concentration was determined by the BCA
assay Protein Quantification Kit. Equal amounts of proteins were heated for 5 minutes at 100°C
in sample buffer and separated by SDS-PAGE under reducing conditions and transferred to ni-
trocellulose membranes. Membranes were saturated in blocking buffer containing 5%milk (w/
v) in TBS-T buffer (50 mM Tris, pH7.5, 150 mMNaCl, 0.1% (v/v) Tween 20) for 1 hour at
room temperature and incubated overnight at 4°C with anti-phospho-T202/Y204-ERK1/2,
anti-ERK1/2, anti-Neu-1, anti-PPCA (kindly provided by Prof. A. d’Azzo, Memphis, USA) or
anti-β-actin (1/1000) antibodies in blocking buffer. After five washes with TBS-T buffer, mem-
branes were incubated for 1 hour at room temperature with HRP-coupled anti-rabbit, -mouse
or -goat secondary antibodies (1/5000) (Cell Signaling) in blocking buffer. Immuno-complexes
were detected by chemiluminescence and quantified by Quantity One software (Biorad).
Real Time-qPCR
Fibroblasts (3.105) were seeded in a 6-well plate in complete DMEMmedium. After 48h of cul-
ture, cells were serum-starved for 18h then stimulated at 50 μg/mL EDP for 24 hours. Total
mRNA were extracted by Trizol then separated from others cellular materials by chloroform/
isoamyl alcohol (24:1) and centrifugated (12000g, 4°C, 15 min). Total mRNA were precipitated
with isopropanol then washed with 75% ethanol and resuspended in water. The quantity of
RNA was determined by spectroscopy and their quality was evaluated by migration on agarose
gel. 250 ng of total mRNA were reverse-transcribed using VERSO cDNA kit (Thermoscientific,
USA) according to the manufacturer’s instructions. RT-qPCR primers were designed accord-
ing to human sequences encoding for EBP, β-Gal, NEU-1, PPCA, RS18 and RPL32 (Table 1).
Immunofluorescence
Fibroblasts (3.104) were seeded on glass slides in 24-well plates in complete DMEMmedium.
After 48h of culture followed by an 18h serum starvation period, cells were stimulated or not
with 50 μg/mL EDP for 30 minutes. Cells were fixed with 4% paraformaldehyde for 15 minutes
and unspecific sites were saturated by 3% bovine serum albumin (BSA) (w/v) for 1 hour at
room temperature. Cells were incubated overnight at 4°C with rabbit polyclonal anti-Neu-1 (1/
100) or anti-PPCA (1/1000) primary antibodies diluted in 0.3% BSA, then washed twice in PBS
and further incubated for 1 hour at room temperature with Alexafluor-568-coupled anti-rabbit
(1/1000) secondary antibodies. After mounting with Prolong Gold Antifade reagent containing
DAPI, the slides were imaged by confocal microscopy (Zeiss).
Sialidase activity assay
Fibroblasts (2.106) were seeded in Petri dishes in complete DMEMmedium. After 48 hours of
culture followed by a 18h serum starvation period, cells were stimulated with PBS or elastin
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peptides (50 μg/mL) for 30 minutes at 37°C. Cells were then washed and crude membranes
were prepared in TEM buffer pH7.5 containing 75 mM Tris pH7.5, 2 mM EDTA, 12 mM
MgCl2, 1mMNa3VO4, 10 mM NaF and protease inhibitor cocktail. Cellular extracts were soni-
cated then centrifuged (600g, 10 min, 4°C). The supernatant was collected and centrifuged
again at 20000g for 45 minutes at 4°C. The crude membrane pellet was suspended in 200 μL of
MES buffer (20 mM 2-(N-morpholino) ethane sulfonic acid, pH 7). 50 μg of crude membranes
were deposited per well in a 24-well plate. They were stimulated in 200 μL MES buffer (pH 7)
containing or not 50 μg/mL EDP and 200 μM of chromogenic substrate para-nitrophenyl-N-
acetylneuraminic acid. After incubation for 4h at 37°C in darkness, the reaction was stopped
with 300 μL of 1M Na2CO3. Finally, sialidase activity was measured by absorbance at 405 nm.
Flow cytometry
Fibroblasts (3.105) were seeded in 6-well plates in complete DMEMmedium. After 48h of cul-
ture, cells were serum-starved for 18h. Fibroblasts were then preincubated with 400 μM of
DANA for 1h then stimulated or not with EDP (50 μg/mL) for 30 minutes at 37°C. After stim-
ulation, fibroblasts were washed with ice-cold PBS containing 50 μMNa3VO4 then harvested
in PBS containing 10 mM EDTA at 4°C. Cells were centrifuged (400g, 10 min, 4°C), washed
with PBS, then incubated with FITC-anti-CD17 antibody (anti-lactosylceramide) or FITC-
anti-IgM control (1/25 dilution) for 20 minutes at room temperature in darkness. Cells were fi-
nally washed, centrifuged and fixed with 500 μL 1% formaldehyde before analysis with a FACS
Calibur cytometer (Becton Dickinson, Le Pont de Claix, France).
Statistical analysis
Results are expressed as mean +/- S.E.M of 3 independent experiments, each run in triplicate.
Comparison between groups were made using two-tailed Student’s t test. The results were con-
sidered significantly different at p<0.05.
Table 1.
Primers Sequence Amplicon (pb)
RS18 forward 5’-GCAGAATCCACGCCAGTACAA-3’ 208
reverse 5’-GCCAGTGGTCTTGGTGTGCT-3’
RPL32 forward 5’-CATTGGTTATGGAAGCAACAAA-3’ 150
reverse 5’-TTCTTGGAGGAAACATTGTGAG-3’
EBP forward 5’-TCCAGACATTACCTGGCAGCT-3’ 111
reverse 5’-ATGTTGCTGCCTGCACTGTT-3’
β-gal forward 5’-GCTGGTTATCCTGAGGCCC-3’ 104
reverse 5’-CGGAGGAGCGGAGAAGAATA-3’
NEU-1 forward 5’-AATGCCCGAAACCAGAACAAC-3’ 239
reverse 5’-CGCCATGAGGTACCATTGCT-3’
PPCA forward 5’-AATCTCTATGCCCCGTGTGCT-3’ 102
reverse 5’-TGGCAGGCGAGTGAAGATG-3’
All primers were synthetized by Eurogentec (Angers, France). Real-time PCR was performed using an Absolute SYBR Green Rox mix (Thermo Electron,
Courtaboeuf, France), and the Chromo Four-Color-Real-Time PCR detection system (Bio-Rad, France). PCR conditions were 15 minutes at 95°C,
followed by 40 cycles each consisting of 15 s at 95°C (denaturation) and 1 minute at 60°C (annealing/extension). PCR efﬁciency of the primer sets (EBP,
β-Gal, Neu-1, PPCA, RS18, and RPL32) was controlled via the slope of a standard curve. Results were standardized to RS18 and RPL32 gene
expression levels using Genex software (BioRad).
doi:10.1371/journal.pone.0129994.t001
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Results
Characterization of the in vitromodel of fibroblast aging
Primary cell sub-cultures were used as an in vitromodel of aging. This model has been reported
to mimic cellular and gene expression modifications observed in normal in vivo aging while
limiting inter-individual variability [45,46].
Morphological changes, decreased replicative capacity, acid β-galactosidase expression [47],
ROS and MMP-1 production are correlated to cellular senescence [48–50]. We therefore ana-
lyzed these parameters to characterize our model of in vitro aging. During the in vitro aging pro-
cess, we observed an increased proportion of senescent cells as shown by β-galactosidase
detection (Fig 1A), a decrease of fibroblast proliferation (Fig 1B), and an increase of ROS pro-
duction (Fig 1C) andMMP-1 secretion (Fig 1D). These data confirmed that cellular senescence
occurred in our model and validated its use for the study of in vitro aging. As a consequence, we
considered “young” fibroblasts to be represented by cells that had undergone 3 passages (white),
“intermediate” fibroblasts with 5 passages (gray) and “aged” cells those with 8 passages (black).
Fig 1. Characterization of the in vitromodel of aging. Young, intermediate and aged fibroblasts are
represented by passage 3 (white), 5 (gray) and 8 (black bars), respectively. Data shown are representative of
three independent experiments. (A) Acid β-galactosidase detection during in vitro aging. Acid β-
galactosidase positive senescent cells appear in blue. The histogram reports the senescent/total cells ratio in
the three conditions. This ratio was set to 100% for p3. (B) Fibroblasts proliferation is decreased during in
vitro aging. Cells were incubated with the Uptiblue reagent and proliferation was evaluated by measuring the
absorbance at 560nm. The results are expressed as a percentage of p3 condition value. (C) Evaluation of
ROS production during in vitro aging. ROS production was detected by fluorescence using the Image-iT LIVE
Green Reactive Oxygen Species Detection Kit. (λ excitation 495nm / λ emission 529nm). The results are
expressed as a percentage of p3 condition value. (D) Evalution of MMP-1 secretion during in vitro aging.
MMP-1 secretion was determined by ELISA. The results are expressed as a percentage of p3 condition
value. *, p<0.05, ***, p<0.01.
doi:10.1371/journal.pone.0129994.g001
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Impact of aging on EDP-induced biological activities
EDP regulate several biological functions such as cell proliferation [9] and MMP-1 production
[10,31]. These effects have been linked to ERK1/2 signaling pathway activation [29,30]. In
order to analyze the impact of aging on EDP signaling, we checked the ability of EDP (kE,
VGVAPG) to induce these biological activities as a function of fibroblast in vitro aging. As pre-
sented in Fig 2A, kE and VGVAPG increased significantly the proliferation of young (by
100%) but their effect was limited and not significant for aged cells. Scramble peptide exhibited
no effect demonstrating the specificity of the stimulation. Similar results were observed on
MMP-1 secretion (Fig 2B). MMP-1 secretion was increased two fold in young cells. However,
the increase observed in oldest cells was not significant. We also analyzed the production of
ROS following EDP treatment but we observed that it had no significant incidence (Fig 2C).
The observations made with cells treated with 50 μg kE/mL were correlated with those made
when cells were treated with 200 μg/mL VGVAPG (Fig 2A and 2B and 2C, p3 and p8), a well-
known EBP agonist. Interestingly, a scramble of the VGVAPG sequence, VVGPGA, could not
reproduce the effect of VGVAPG demonstrating the specificity of the stimulation [10,40].
As stated earlier, the biological activities of EDP involve the activation of the MAPK ERK1/
2 signaling pathway [30,31]. We thus checked the ability of EDP to induce the activation of the
MEK/ERK pathway in our model of in vitro aging. As reported in Fig 2D, we observed that
EDP significantly increased by 37% the phosphorylation rate of ERK1/2 in young cells, while
they had no significant effect in oldest cells (Fig 2D).
In conclusion, our results show that in our in vitro aging model, EDP have lost their ability
to trigger biological processes in aged cells. These data suggested, as proposed by others
[13,32,33], an age-related uncoupling of ERC from its signaling pathways.
Analysis of mRNA and protein expression levels of ERC sub-units
The decrease of EDP-mediated effects does not imply a modification of EBP expression nor af-
finity [34]. We therefore hypothesized that a modification of the mRNA expression and pro-
tein production of the others partners of the complex (Neu-1/PPCA) could account for
this decrease.
The expression level of the three ERC subunits was evaluated by RT-qPCR (Fig 3). Our
data evidenced no mRNA levels changes for the EBP, PPCA and NEU-1 subunits (Fig 3A).
Importantly, the EBP/β-Gal expression ratio remained unchanged throughout the in vitro
aging process. Strikingly, the transcription levels of ERC subunits were not affected by cell
aging (p3, p5 or p8) either in resting or EDP-stimulated conditions (Fig 3B). Altogether,
these data indicated that age-related modifications of ERC subunits transcription could not
account for the ERC uncoupling.
As EBP protein levels showed no variation during aging [34], we focused on Neu-1 and
PPCA protein levels and their localization (Fig 4). As reported in Fig 4A, neither NEU-1 nor
PPCA protein levels were changed between young, intermediate and old cells. This was ob-
served both in resting conditions and after EDP treatment. We therefore hypothesized that
ERC location at the plasma membrane could be changed with age. However, immunofluores-
cence plasma membrane localization studies showed no changes in Neu-1 and PPCA localiza-
tion during aging (Fig 4B). We therefore concluded that the protein levels and the localization
of the two ERC subunits remained unchanged during aging and could not explain the age-re-
lated uncoupling of ERC. We further hypothesized that a modification of Neu-1 enzymatic ac-
tivity could explain this uncoupling.
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Fig 2. Impact of in vitro aging on EDP biological effects. Young and aged fibroblasts were represented by
passage 3 (white) and 8 (black bars), respectively. Dotted lines (100%) represent the values of the
unstimulated controls. (A) Impact of in vitro aging on EDP-mediated fibroblast proliferation. Cells were
stimulated or not with 50 μg/mL of EDP or 200 μg/mL of scramble or VGVAPG peptides during 48h.
Proliferation was analyzed by counting using Trypan Blue exclusion. (B) Impact of in vitro aging on EDP-
Elastin Receptor Complex Uncoupling Mechanism
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Age-related alterations of EDP-induced sialidase activity
Gangliosides are known to modulate several signal transduction processes [51,52]. GM3 gangli-
oside is a substrate of Neu-1 and its desialylation following EDP treatment leads to LacCer pro-
duction, a second messenger able to activate ERK1/2 pathway [28,29].
In order to evaluate if Neu-1 sialidase activity could be affected by aging, we measured the
effect of EDP on Neu-1-mediated sialidase activity as a function of age using a chromogenic
substrate (Fig 5A). As compared to young cells, basal sialidase activity in crude membranes of
intermediate and old cells showed a two-fold and three-fold increase respectively. The same
assay was performed from EDP-stimulated cells. A significant sialidase activity increase (50%)
was observed in young fibroblasts (Fig 5B). This increase was lower for intermediate cells
(+20%) and lost in aged cells. These data suggested that uncoupling of ERC from its signaling
pathway could be due to a loss of sialidase activity stimulability following EDP treatment.
EDP-induced LacCer production as a function of age
To evaluate if the modification observed in sialidase activity could be translated to a change in
LacCer production, this lipid was measured by flow cytometry throughout the in vitro aging
process. Our results (Fig 6A) demonstrated a progressive and significant increase of basal Lac-
Cer presence with aging. LacCer levels reached a maximal production in aged fibroblast with a
50% increase as compared to young cells. The augmentation of LacCer production correlated
with the evolution of sialidase activity during in vitro aging and was blocked after addition of
DANA, a well-known sialidase inhibitor (Fig 6B). The stimulation of cells with EDP induced a
significant increase of LacCer production in young fibroblasts (+50%). This increase was com-
parable in intermediate cells but was lost in aged ones (Fig 6B). Moreover, we showed that
DANA treatment inhibited EDP effects on LacCer production demonstrating Neu-1 involve-
ment in LacCer production. Our results therefore suggested that ERC uncoupling is due to an
age-dependent loss of EDP ability to trigger LacCer production.
Discussion
In pathophysiological conditions, elastin is degraded and generates elastin peptides possessing
several biological functions [5]. Indeed, through their capacity to regulate chemotaxis [8], pro-
liferation [9], protease synthesis [10,14–16], and by modulating the immune system [6], EDP
are involved in the progression of diverse diseases, such as cancer and cardiovascular patholo-
gies, but also in physiological conditions like healing and aging [53]. EDP effects are triggered
after their binding on the ERC, leading to the activation of Neu-1 sialidase activity. As a conse-
quence, this enzyme converts the GM3 ganglioside to LacCer, a second messenger [28,29].
However, it has been described that the biological effects induced by EDP are modified with
aging. Indeed, diverse group showed age-related alterations in EDP signaling [13,32,33] which
did not involve a modification of EBP binding sites nor affinity [34].
induced MMP-1 secretion on fibroblasts. MMP-1 secretion was evaluated by ELISA. Cells were stimulated
with 50 μg/mL of EDP or 200 μg/mL of scramble or VGVAPG peptides during 24h. (C) Impact of in vitro aging
on EDP-induced ROS production. Cells were stimulated for 30 minutes with 50 μg/mL of EDP or 200 μg/mL
of scramble or VGVAPG peptides. ROS were detected by the Image-iT LIVE Green Reactive Oxygen
Species Detection Kit as described. (D) Impact of in vitro aging on EDP-induced ERK1/2 activation. ERK1/2
phosphorylation was analyzed byWestern blotting after 30 min of stimulation with 50 μg/mL of EDP. Cells
extracts were analyzed using anti-phospho-ERK1/2 (T202/Y204) and anti-ERK1/2 antibodies. The blots are
presented in the left panel. The corresponding densitometric analysis is provided on the right panel. *,
p<0.05, ** p<0.02, *** p<0.01.
doi:10.1371/journal.pone.0129994.g002
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Fig 3. mRNA expression analysis of the three subunits of the elastin complex receptor during in vitro
aging. Young, intermediate and aged fibroblasts were represented by passage 3 (white), 5 (gray) and 8
(black bars). (A) mRNA expression of EBP, NEU-1 and PPCA during in vitro aging. (B) Impact of EDP on
ERC subunits expression during in vitro aging. mRNA levels were analyzed after 24 hours of stimulation with
50 μg/mL of EDP or 200 μg/mL of scramble or VGVAPG peptides. Results are expressed as 1/dCT. Each
data are representative of three independent experiments. No significant differences were observed.
doi:10.1371/journal.pone.0129994.g003
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We used an in vitromodel of aging to study its impact on the biological effects of EDP. The
successive subculturing is considered to be a good method to develop an in vitromodel of
aging [45,46]. This method reproduces the same age-related modifications such as decrease of
replicative capacity, morphological changes [46], increase in acid β-galactosidase expression
[47] and an augmentation of ROS production and MMP-1 secretion [48,49]. These senescence
Fig 4. Analysis of protein expression and plasmamembrane localization of Neu-1 and PPCA. Young,
intermediate and aged fibroblasts were represented by passage 3 (white), 5 (grey) and 8 (black bars). (A)
Analysis of Neu-1 and PPCA protein levels during aging. Cells were stimulated or not for 24 hours with 50 μg/
mL of EDP before protein extraction. Neu-1 and PPCA were then analyzed byWestern blotting using anti-
Neu-1 and anti-PPCA antibodies. Densitometric analysis was performed using the Quantity One software.
The results were expressed as the ratio Neu-1/β-actin and PPCA/β-actin and normalized to the control
expressed in percent. Dotted lines (100%) represent the values of the unstimulated controls. (B) Analysis of
Neu-1 and PPCA localization during aging. Neu-1 and PPCA cell localizations were analyzed by confocal
microscopy. Bar, 10 μm.
doi:10.1371/journal.pone.0129994.g004
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markers were used to characterize our model and to confirm the induction of an efficient in
vitro aging.
EDP stimulate the proliferation of normal cells, such as fibroblasts [9,54,55] and smooth
muscle cells [56], but also tumor cells from glioblastoma [57] and melanoma [15]. Consistently
with literature data, our results demonstrated that EDP induce cell proliferation. However, this
effect was lost in aged cells. Indeed, EDP-induced proliferation was observed in young and in-
termediate fibroblasts but not with aged fibroblasts. We also showed that EDP are not able to
significantly trigger ROS production in young or old fibroblasts. The elastin peptides-induced
ROS production has been reported in monocytes/macrophages [18]. However, inhibition of
ROS production has been reported in EDP-treated neutrophils [58] suggesting that the ability
of elastin peptides to trigger or not this process is cell-dependent. Our results suggest that elas-
tin peptides are not able to regulate ROS production by fibroblasts, reinforcing this hypothesis.
MMP-1 up-regulation by EDP has been described in both normal and tumor cells, such as
endothelial cells [11], fibroblasts [10], melanoma [15] and fibrosarcoma [59]. In this study, we
show that this EDP-induced MMP-1 up-regulation is altered with age.
EDP-mediated MMP-1 production involves the activation of the MEK/ERK pathway
through both PKA- and PI3K-dependent signaling [30]. As observed for EDP-mediated
Fig 5. Impact of aging on EDP-induced sialidase activity. Young, intermediate and aged fibroblasts were
represented by passage 3 (white), 5 (gray) and 8 (black bars). (A) Basal sialidase activity increases with age.
Sialidase activity assay was performed on crude membrane using the chromogenic substrate para-
nitrophenyl-NANA for 4 hours at 37°C. (B) EDP-mediated sialidase activity is altered with age. Cells were
stimulated or not with 50 μg/mL of EDP for 30 minutes then crude membrane were prepared and used to
measure sialidase activity. Histogram represent the normalized results relative to the control expressed in
percent. Each data is representative of three independent experiments. ***, p<0.01. Dotted lines represent
the values of the unstimulated controls.
doi:10.1371/journal.pone.0129994.g005
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MMP-1 secretion, we showed that only young and intermediate fibroblasts could trigger
ERK1/2 signaling pathway in the presence of EDP, suggesting an uncoupling of EDP signaling
in aged fibroblasts. Several molecular alterations in ERC-induced signaling pathways has been
previously describe such as modification of Gi protein activation [33], alteration of calcium sig-
naling [60,61] and modulation of ERK1/2 phosphorylation [62]. From these data, we hypothe-
sized that the uncoupling of ERC involved a modification of upstream molecular events.
It has been shown that alteration of EDP signaling with age does not imply a modification
of EBP expression and affinity [34]. Moreover, we show that aging does affect neither the
mRNA expression of the ERC subunits nor the protein levels of PPCA and Neu-1. We there-
fore concluded that mRNA or protein expression of the receptor sub-units could not account
for the age-related uncoupling of ERC.
Accordingly, we supposed that age-related alterations in EDP signaling would involve the
first steps of their signaling cascade. Indeed, modifications of Neu-1 sialidase activity or plasma
membrane composition could explain the age-related uncoupling of ERC. Gangliosides are si-
alic acid-containing glycosphingolipids found in microdomains of the plasma membrane.
They are involved in cellular interactions and in signal transduction processes [51,52]. Binding
Fig 6. Impact of aging on EDP-induced LacCer production. Young, intermediate and aged fibroblasts
were represented by passage 3 (white), 5 (gray) and 8 (black), respectively. (A) Basal LacCer production
increases with age. LacCer production was detected by flow cytometry using a specific FITC-coupled anti-
LacCer antibody (anti-CD17). DANA was used to study the impact of sialidase inhibition on basal production
of LacCer during in vitro aging. (B) EDP-mediated LacCer production is altered with age. Cells were
stimulated or not with 50 μg/mL of EDP for 30 minutes in the presence or not of DANA. LacCer production
was then analyzed by flow cytometry as described above. Histograms represent the normalized results
relative to the control expressed in percent. Each data is representative of three independent experiments. *,
p<0.05, ***, p<0.01. Dotted lines represent the values of the unstimulated controls.
doi:10.1371/journal.pone.0129994.g006
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of EDP to EBP triggers Neu-1 sialidase activation leading to the conversion of GM3 ganglioside
to LacCer, which behaves as a second messenger and transduces EDP signaling [28,29]. Our re-
sults evidenced an increase in basal sialidase activity with age but also an alteration of EDP-in-
duced sialidase activity. Such variation has been already reported by Saito et al who described
age-dependent modulations of sialidase activity in synaptic plasma membrane isolated from
mice brain [63]. Moreover, we observed an increase of basal LacCer production levels as a func-
tion of age. Strikingly, we observed that this age-related LacCer production could be due to in-
creased sialidase activity as the use of DANA significantly reduced LacCer production.
Interestingly, LacCer production following EDP treatment was altered during aging. The ability
of EDP to promote LacCer formation was lost in aged fibroblasts as compared to young and in-
termediate ones. The use of DANA suggested that Neu-1 was involved in this EDP-mediated
LacCer production.
Overall, our data suggest, for the first time, that a modification of basal Neu-1 activity and
the subsequent alteration in LacCer production could be responsible for the alteration of EDP
signaling observed with aging. Moreover, as Neu-1 is involved in elastogenesis through the
desialylation of microfibrils [39,64], an EBP-tropoelastin bound dependent process, our data
point out that the deregulation of its activity during aging could partly explain the difficulty en-
countered to achieve an efficient elastogenesis in aged individuals.
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